Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$2.57 - $8.16 $105,596 - $335,278
-41,088 Reduced 60.78%
26,512 $71,000
Q4 2022

Feb 14, 2023

BUY
$5.19 - $13.5 $350,844 - $912,600
67,600 New
67,600 $367,000
Q3 2021

Nov 15, 2021

SELL
$13.16 - $22.47 $5.26 Million - $8.98 Million
-399,844 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$19.57 - $26.32 $4.89 Million - $6.58 Million
249,908 Added 166.68%
399,844 $8.77 Million
Q1 2021

May 17, 2021

BUY
$17.58 - $32.59 $2.51 Million - $4.65 Million
142,736 Added 1982.44%
149,936 $3.61 Million
Q4 2020

Feb 16, 2021

BUY
$10.99 - $20.4 $79,128 - $146,880
7,200 New
7,200 $130,000
Q3 2020

Nov 16, 2020

SELL
$11.55 - $23.75 $1.2 Million - $2.47 Million
-104,157 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$9.57 - $24.37 $996,782 - $2.54 Million
104,157 New
104,157 $2.53 Million
Q3 2018

Nov 14, 2018

SELL
$43.15 - $67.97 $5.22 Million - $8.22 Million
-120,865 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$35.06 - $51.17 $3.62 Million - $5.28 Million
-103,135 Reduced 46.04%
120,865 $5.25 Million
Q1 2018

May 15, 2018

BUY
$19.05 - $41.76 $457,200 - $1 Million
24,000 Added 12.0%
224,000 $8.3 Million
Q4 2017

Feb 14, 2018

BUY
$19.01 - $26.2 $3.8 Million - $5.24 Million
200,000
200,000 $3.97 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.